Mandibular ameloblastic fibroma: enucleation and 3 years follow up. Case report and literature review

Gutierrez, F Orensanz; Badilla, R.; Cerdá, Paula

doi:10.1016/j.ijom.2017.02.1027

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The luminal type of unicystic ameloblastoma presents and develops as a cyst and is considered in the differential diagnosis of the dentigerous cyst, and is managed similarly [ 4 ]. Adenomatoid odontogenic tumor (AOT) and ameloblastic fibroma are also rare and benign epithelial odontogenic tumors that are noninvasive, grow slowly, and usually have no recurrence [ 5 ]. These tumors have different biological behaviors and histopathologies.…”

Section: Introductionmentioning

confidence: 99%

CDC7 Expression in Selected Odontogenic Tumors

Jaafari‐Ashkavandi

Alizadeh

2022

International Journal of Dentistry

View full text Add to dashboard Cite

Objectives. CDC7 is a serine-threonine kinase that plays a key role in initiating DNA replication. It has been implicated in the growth and invasion of many pathologic lesions and suggested as a diagnostic marker. The aim of this study was to evaluate CDC7 in some odontogenic tumors. Materials and Methods. In this cross-sectional study, 45 cases, including 19 ameloblastomas, 15 dentigerous cysts, 7 ameloblastic fibromas, and 4 adenomatoid odontogenic tumors (AOT), were studied immunohistochemically. ANOVA and post hoc methods were used for statistical analysis. Results. CDC7 expression was observed in 93% of tumors and all dentigerous cysts. The expression rate was low. The results showed a higher expression rate of CDC7 in ameloblastoma and ameloblastic fibroma compared to AOT ( p = 0.009 and p = 0.048 , respectively). Ameloblastoma and ameloblastic fibroma were not significantly different in CDC7 expression ( p = 0.6 ). Conclusion. According to the results, the expression of the CDC7 protein in odontogenic tumors is low. The higher expression of CDC7 in ameloblastoma and ameloblastic fibroma in comparison with AOT confirms the hamartomatous growth of the latter, so it can be considered as a potential diagnostic marker. Future studies with a larger sample size are suggested to obtain a cut-off point for diagnostic purposes.

show abstract

Section: Introductionmentioning

confidence: 99%